Mobile-Version anzeigen
This project develops an AI-supported PoC for pharmaceutical target value assessment, combining public data, LLMs and agent-based workflows to generate evidence-based, traceable insights for portfolio and development decisions.
Laufend
01.09.2026 - 31.12.2026
Forschung
IDN Gesundheit